Chemomab Therapeutics Ltd.
CMMB
Last
$1.38
Day
-0.7%
1y
-58.8%
5y
-96.6%
52w
-60.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
1.80
EMA 50
1.97
EMA 200
2.13
20d high
-51.7%
5y high
-97.4%
5y range
1th
Positions held
Your positionsCMMB isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.79
Stop
$1.05
Stop distance
23.9%
Target vs last
+29.7%
Fundamentals
| Market cap | $10.19M | Enterprise value | $3.38M | Trailing P/E | — | Forward P/E | -46.33 |
| PEG | — | Price / book | 1.16 | Beta | 0.74 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -82.2% | ROA | -46.3% | Debt / equity | — |
| Current ratio | 6.41 | Free cash flow | -$6.19M | Analyst recommendation | none | Mean target | $5.00 |
| 52w high | $3.55 | 52w low | $1.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$2.2M | -$1.8M | -$1.9M | -$1.7M | -$2.1M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$2.2M | -$1.9M | -$2.0M | -$1.8M | -$2.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$9.0M | -$13.9M | -$24.2M | -$27.6M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$9.6M | -$14.7M | -$25.5M | -$28.5M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsCMMB · daily-41.6% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin